Anti-thymocyte Globulin (Rabbit) (Thymoglobulin)
Anti-thymocyte Globulin (Rabbit) is an FDA-licensed reference biologic from Genzyme Corporation. Reference exclusivity, biosimilar lineage, and published patents from official FDA Purple Book records.
0
Biosimilars
0
Interchangeables
0
Listed patents
1999
Reference approved
Reference product
Thymoglobulin Anti-thymocyte Globulin (Rabbit)
Genzyme Corporation
- Approved
- May 19, 1999
- Marketing
- Rx
- Center
- CBER
- Patents
- None listed
Exclusivity & patent cliffs
Approval, exclusivity, and published-patent expiration dates for Anti-thymocyte Globulin (Rabbit), in chronological order.
Reference approval
Approval date of the reference Anti-thymocyte Globulin (Rabbit) product.
27 yr 5 mo ago
Frequently asked questions
Are there biosimilars approved for Anti-thymocyte Globulin (Rabbit) (Thymoglobulin)?
No 351(k) biosimilars or interchangeable biosimilars referencing Anti-thymocyte Globulin (Rabbit) are listed in the FDA Purple Book yet.
Explore the full FDA Purple Book
Search every FDA-licensed biologic, biosimilar, and interchangeable with exclusivity timelines and patent records.